Zhexun Sun

Zhexun (Jason) Sun is a cofounder and director of innovation and chemistry at Pleryon Therapeutics, a position held since April 2020. Prior to this role, Zhexun served as a postdoctoral researcher at Cornell University from September 2018 to March 2020 and worked as a consulting specialist at iFyber between November 2018 and June 2019. Zhexun earned a Doctor of Philosophy (PhD) in Biomedical Engineering from Cornell University, completing the degree in 2018, and has a background that includes education from Rutgers University.